TABLE VII.
Treatment Regimena | ORR (%) | PFS (months) | OS (months) |
---|---|---|---|
Chemo alone | 16 | 3.3 | 5.7 |
Chemo + BSI 201 | 48 | 6.9 | 9.2 |
Patients were randomized to receive either Carboplatin + Gemcitabine (chemo) alone or Carboplatin + Gemcitabine + BSI 201 (PARP-I; iniparib).
Chemo = chemotherapy; ORR = overall response rate; OS = overall survival; PARP = poly ADP-ribose polymerase; PFS = progression-free survival